Malin Corporation | MLC - Assets


Malin Corporation reported EUR198.5M in Assets for its fiscal semester ending in December of 2024.





Assets Change Date
Akebia Therapeutics USD 364.15M 18.56M Sep/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
ALKERMES USD 2.33B 76.7M Sep/2025
Avita Medical AUD 58.13M 21.58M Jun/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Eurofins Scientific SE EUR 10.99B 399.1M Dec/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Lonza CHF 19.73B 1.85B Dec/2024
Malin Corporation EUR 198.5M 70.1M Dec/2024
Moderna USD 12.34B 203M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Ovoca Bio EUR 11.41M 3.36M Jun/2022
Revvity USD 12.17B 29.46M Dec/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Viatris USD 37.92B 491.1M Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025